RNAseq analysis for the diagnosis of muscular dystrophy

Annals of Clinical and Translational Neurology

Volumn 3, Issue 1, 2016, Pages 55-60

  Gonorazky, Hernan ^a,b   Liang, Minggao ^a,c   Cummings, Beryl ^d,e   Lek, Monkol ^d,e   Micallef, Johann ^a   Hawkins, Cynthia ^a   Basran, Raveen ^a   Cohn, Ronald ^a,b,c   Wilson, Michael D ^a,c   Macarthur, Daniel ^d,e   Marshall, Christian R ^a   Ray, Peter N ^a,c   Dowling, James J ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; TRANSCRIPTOME;

ARTICLE; CASE REPORT; CHILD; DNA BARCODING; DOWN REGULATION; EXON; GENE; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE;

EID: 85009822352     PISSN: None     EISSN: 23289503     Source Type: Journal    
DOI: 10.1002/acn3.267     Document Type: Article

References (20)

1. Landfeldt E, Lindgren P, Bell CF, et al. The burden of Duchenne muscular dystrophy: an international, cross-sectional study. Neurology 2014;83:529-536.
2. Lopez-Bastida J, Oliva-Moreno J. Cost of illness and economic evaluation in rare diseases. Adv Exp Med Biol 2010;686:273-282.
3. Chelly J, Desguerre I. Progressive muscular dystrophies. Handb Clin Neurol 2013;113:1343-1366.
4. Ankala A, da Silva C, Gualandi F, et al. A comprehensive genomic approach for neuromuscular diseases gives a high diagnostic yield. Ann Neurol 2015;77:206-214.
5. Wong SH, McClaren BJ, Archibald AD, et al. A mixed methods study of age at diagnosis and diagnostic odyssey for Duchenne muscular dystrophy. Eur J Hum Genet 2015;1294-300.
6. Jiang T, Tan MS, Tan L, Yu JT. Application of next-generation sequencing technologies in Neurology. Ann Transl Med 2014;2:125.
7. Yang Y, Muzny DM, Reid JG, et al. Clinical whole-exome sequencing for the diagnosis of Mendelian disorders. N Engl J Med 2013;369:1502-1511.
8. Baskin B, Banwell B, Khater RA, et al. Becker muscular dystrophy caused by an intronic mutation reducing the efficiency of the splice donor site of intron 26 of the dystrophin gene. Neuromuscul Disord 2009;19:189-192.
9. Ruggieri A, Ramachandran N, Wang P, et al. Non-coding VMA21 deletions cause X-linked myopathy with excessive autophagy. Neuromuscul Disord 2015;25:207-211.
10. Trabelsi M, Beugnet C, Deburgrave N, et al. When a mid-intronic variation of DMD gene creates an ESE site. Neuromuscul Disord 2014;24:1111-1117.
11. Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010;9:77-93.
12. Irimia M, Weatheritt RJ, Ellis JD, et al. A highly conserved program of neuronal microexons is misregulated in autistic brains. Cell 2014;159:1511-1523.
13. Dobin A, Davis CA, Schlesinger F, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 2013;29:15-21.
14. Harrow J, Frankish A, Gonzalez JM, et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 2012;22:1760-1774.
15. Trapnell C, Hendrickson DG, Sauvageau M, et al. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol 2013;31:46-53.
16. Kevelam SH, Taube JR, van Spaendonk RM, et al. Altered PLP1 splicing causes hypomyelination of early myelinating structures. Ann Clin Transl Neurol 2015;2:648-661.
17. Ku CS, Wu M, Cooper DN, et al. Exome versus transcriptome sequencing in identifying coding region variants. Expert Rev Mol Diagn 2012;12:241-251.
18. Waddell LB, Monnier N, Cooper ST, et al. Using complementary DNA from MyoD-transduced fibroblasts to sequence large muscle genes. Muscle Nerve 2011;44:280-282.
19. Tsunemoto RK, Eade KT, Blanchard JW, Baldwin KK. Forward engineering neuronal diversity using direct reprogramming. EMBO J 2015;34:1445-1455.
20. Bellin M, Marchetto MC, Gage FH, Mummery CL. Induced pluripotent stem cells: the new patient? Nat Rev Mol Cell Biol 2012;13:713-726.